Athos Therapeutics Stock
Athos Therapeutics is a clinical-stage biotechnology company pioneering the development of artificial intelligence-based precision therapeutics for patients with autoimmune and chronic inflammatory diseases. Founded in 2019, the company integrates medicinal chemistry and systems biology through machine learning to identify and develop novel drug compounds.
Founded: 2019
For more Athos Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Dimitrios Iliopoulos, PhD President and Chief Executive Officer |
| Allan Pantuck, MD Chairman and Chief Medical Officer |
| Keith Hoffman, PhD Chief Business Officer |
| Iordanis Karagiannidis, PhD Chief Scientific Officer |
